Otsuka Holdings Co., Ltd. (4578) Stock Price

Otsuka Holdings operates diverse business segments centered on healthcare. The company is organized into medical-related business, nutraceuticals-related business, consumer-related business, and other operations. It manufactures and sells prescription pharmaceuticals, functional foods, and consumer products both domestically and internationally.

In the medical-related business, Otsuka Pharmaceutical and Taiho Pharmaceutical provide prescription drugs domestically and globally. Key products include Abilify, a treatment for schizophrenia and bipolar disorder, and Lonsurf, a cancer treatment drug. These products play important roles in treating mental illness and cancer.

In the nutraceuticals-related business, Otsuka Pharmaceutical leads the segment, offering the sports drink Pocari Sweat and the nutritional supplement CalorieMate. These products are widely recognized for supporting daily health maintenance and nutritional supplementation.

In the consumer-related business, Otsuka Foods provides mineral water such as Crystal Geyser and ready-to-eat foods like Bon Curry. These products are popular for enhancing convenience in daily life.

In other operations, Otsuka Chemical manufactures chemical products, and Otsuka Electronics provides measurement instruments. Additionally, Otsuka Warehouse operates logistics services that support product distribution across the entire group. This enables an efficient supply chain.

Otsuka Holdings pursues a distinctive growth strategy based on its corporate philosophy: "Otsuka-people creating new products for better health worldwide." The company has established a long-term vision through 2035, focusing on three priority areas: global environment, women's health, and an aging society with fewer children. Through these initiatives, the company aims to realize total healthcare by advancing personalized medicine and delivering new health value.

The Fourth Medium-Term Management Plan, covering fiscal years 2024 through 2028, is positioned as "promoting investment to expand new businesses and generate next-generation growth—five years of creation and growth." The company strengthens investment in its core business platforms centered on healthcare-related and nutraceuticals-related operations, driving new value creation that leads to well-being.

The company establishes new revenue growth drivers backed by new product portfolios, targeting growth in both sales and profit. In healthcare-related operations, it enriches its late-stage development pipeline to create innovative new drugs. In nutraceuticals-related operations, it promotes growth across social-issue-focused categories and advances brand establishment in global markets.

As a financial strategy, the company manages performance using ROIC and ROE metrics while continuing aggressive growth investments. It also enhances shareholder returns and practices management with awareness of capital costs. These efforts aim to achieve sustainable growth and improved profitability.

Otsuka Holdings strengthens its position as a total healthcare company while adapting to changing social environments. The company incorporates new technologies and market needs to drive sustainable growth. Through these initiatives, it works toward solving social challenges and realizing a healthy, sustainable society.